Lavior Pharma Announces The Addition Of Dr. Charles Argoff To The Scientific Executive Advisory Board - Lavior

Lavior Pharma Announces The Addition Of Dr. Charles Argoff To The Scientific Executive Advisory Board

MIAMI, FL (FEBRUARY 6, 2024) – Lavior Pharma Inc., an International advanced diabetic wound and skincare Company headquartered in Miami, Florida, announced the appointment of Charles Argoff, MD, to the Company’s Scientific Executive Advisory Board. Dr. Argoff is Professor of Neurology at Albany Medical College, Vice Chair, Department of Neurology, Director of the Comprehensive Pain Center at Albany Medical Center, and Director of the Pain Management Fellowship in Albany, NY. Dr. Argoff received his medical degree from Northwestern University’s Feinberg School of Medicine in Chicago, Illinois. He completed an internship in the Department of Medicine and a residency in the Department of Neurology at the State University of New York in Stony Brook and a fellowship in developmental and metabolic neurology at the National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS). He is an internationally recognized expert and speaker in Neurology and Pain Management.

Dr. Argoff is a member of the American Academy of Neurology, the International Association for the Study of Pain, the American Academy of Pain Medicine, the Eastern Pain Society and the New York State Pain Society.   He is the President-Elect of the American Academy of Pain Medicine, as well as Past President of the American Academy of Pain Medicine Foundation and the New York State Pain Society.  He is one of the editors of the recently published textbook Raj’s Practical Management of Pain, 6th Edition, and co-author of Defeat Chronic Pain Now, a book written for people with chronic pain.  He has recently published the fourth edition of Pain Management Secrets.  He is on the editorial board for the Clinical Journal of Pain.  Dr. Argoff had an active role in the development of the diabetic peripheral neuropathic pain guidelines published in Mayo Clinic Proceedings, and he has contributed to other published neuropathic pain treatment guidelines.

Dr. Argoff shares, “I am excited to be invited to join Lavior’s Scientific Executive Advisory Board. Lavior’s comprehensive and impressive product line and research pipeline for diabetes, skincare, and other disease states provides an opportunity for all clinicians and patients to find safe, effective, and affordable treatment solutions. I look forward to working with them in their efforts to heal patients worldwide.”

“We welcome Dr. Argoff to our Scientific Executive Advisory Board. Bringing his expert knowledge in neurology, pain, and regulatory areas will assist Lavior in our ongoing efforts to broaden and strengthen our product lines, pipeline products, and ongoing research and development initiatives. He adds to our growing group of internationally recognized experts on our scientific advisory team who validate Lavior’s place as a leader in the healthcare space,” says Gilad Savion, the CEO and President of Lavior.

About Lavior Pharma Inc.

LAVIOR is the only company exclusively dedicated to the therapeutic diabetes skin care market.  The LAVIOR skincare product line soothes and heals some of the most widespread and challenging skin problems – diabetic ulcers, wounds, burns, eczema/atopic dermatitis, bacterial and fungal infections, skin irritations, and cracked skin. LAVIOR’s line of products is based on the proven efficacy of the Inula AGS RIED botanical species. They are developed using the highest quality, pharmaceutical grade ingredients; manufactured and tested to deliver safe, effective, and compliant products. Backed by over 13 years of extensive research and clinical trials, proven clinical safety and efficacy, they consistently outperform conventional treatments.

For more information on Lavior Pharma and its products, please visit www.lavior.com

For Media or other Inquiries, please contact:

Anabelle Savion
Managing Director
Phone: (+1) 9178373355
anabelle@lavior.com